China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- New star orators born as over 1,500 HK students vie for honors
- Seminar urges growth of people's well-being on both sides of Taiwan Strait
- Xi reaffirms China's commitment to friendly cooperation, international equity
- Xi returns to Beijing after state visit to Russia, attending Great Patriotic War victory celebrations
- National science and technology backyard conference held in Hebei
- China's AG600 large amphibious aircraft completes crosswind flight tests
